Merck Sees $1.5M in Unusual Call Activity as Stock Trades Near 52-Week Highs

By TrendSpider Editor

Merck & Company, Inc. (MRK) is attracting significant bullish options interest today, with five unusual call contracts totaling $1,513,780.80 in premium changing hands as the stock trades at $144.895, down 1.60% on the session. All five contracts flagged are calls, with zero puts in the mix, sug

Merck Sees $1.5M in Unusual Call Activity as Stock Trades Near 52-Week Highs

Merck & Company, Inc. (MRK) is attracting significant bullish options interest today, with five unusual call contracts totaling $1,513,780.80 in premium changing hands as the stock trades at $144.895, down 1.60% on the session. All five contracts flagged are calls, with zero puts in the mix, suggesting traders are positioning for upside despite today's mild pullback. With MRK sitting near the upper end of its 52-week range of $82.04 to $156.92, the options flow points to conviction that the stock has further room to run.

Key Drivers of the MRK Stock Move

The forward setup for MRK is constructive from a positioning standpoint. The concentration of activity in November expiries signals that traders expect a catalyst or continued momentum before month-end. MRK has been navigating a complex macro and pipeline environment in 2026, and with the stock still commanding a significant premium above its 52-week low of $82.04, bulls appear confident the broader uptrend remains intact. The mix of in-the-money and out-of-the-money strikes suggests both income-oriented and speculative players are involved, which broadens the conviction signal beyond a single directional bet.

MRK Unusual Options Activity

All five flagged contracts today are calls, with no put activity recorded. Here is a breakdown of each:

Three of the five contracts are in the money at the current price of $144.895, while the two $150 strike contracts are out of the money. The $120 strike contracts carry the most aggressive open interest readings at 1,000%, indicating volume far exceeding existing positions and pointing to fresh, conviction-driven accumulation.

MRK Seasonality

Late October and November have historically been active periods for large-cap pharmaceutical names, as third-quarter earnings results and pipeline updates often drive significant price movement heading into year-end. The clustering of November expirations in today's flow aligns with traders positioning ahead of that seasonally event-rich window.

MRK Relative Performance

MRK is down 1.60% on the session at $144.895, underperforming on the day but still trading in the upper half of its 52-week range of $82.04 to $156.92. The stock sits roughly 8% below its 52-week high, suggesting there is meaningful technical headroom if the bullish options thesis plays out over the next several weeks.

More on MRK

Latest Market News